High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma. (2nd January 2021)

• Record Type: Journal Article
• Authors: Jeong, Hang Yeon; Kim, Hyun-Jin; Kim, Cheol-Eun; Lee, Seongsoo; Choi, Moon-Chang; Kim, Sung-Hak
• Is Part Of: International journal of neuroscience. Volume 131:Number 1(2021)
• Page Start: 7
• Page End: 14
• Publication Date: 2021-01-02
• Subjects: RFX4 -- glioblastoma multiforme -- glioma stem cell -- terminal differentiation; Nervous system -- Periodicals; 612.805
• DOI: 10.1080/00207454.2020.1732969
• Languages: English
• ISSNs: 0020-7454

Abstract

Abstract: Aim: Glioma stem cells (GSCs) have been shown to contribute to tumor development and recurrence, therapeutic resistance, and cellular heterogeneity of glioblastoma multiforme (GBM). Recently, it has been reported that GSCs lose their self-renewal ability and tumorigenic potential upon differentiation. In this study, we identified Regulatory Factor X4 ( RFX4 ) gene to regulate GSCs' survival and self-renewal activity in the GBM patients samples. Materials and methods: We utilized public datasets from the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), Ivy Glioblastoma Atlas Project, and The Human Protein Atlas to screen candidate genes which are associated with the development of GBM and poor patients survival. Small hairpin RNA (shRNA) lentivirus was applied to knockdown RFX4 gene in GSCs. Results: We found that RFX4 mRNA expression among the RFX family was particularly reduced during GSC differentiation. RT-qPCR analysis revealed significant downregulation of RFX4 and stem cell markers ( CD15 and CD133 ) mRNA expressions in primary human GBM-derived GSCs cultured under serum condition. Consistently, GSCs showed significantly elevated RFX4 mRNA expression levels compared to normal astrocytes, NHA, whereas glioma cells did not. Furthermore, analysis of the TCGA data set revealed that RFX4 is highly expressed in GBM, and contributes to the lowering of patient survival. Depletion of RFX4 using shRNA lentivirus in patient GBM-derived GSCs decreased neurosphere formation and cell viability. Conclusion: These results suggest that RFX4 is a potential risk factor for maintaining the stemness of GSCs and making glioma more malignant, and thus, could be a promising target of GBM treatment.